The Upside of Suicide

Researchers show that a bacterium’s self-sacrifice can benefit its community, even when the members are not strongly related.

Written bySabrina Richards
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Colonies of altruistic Escherichia coli lambda (green) and selfish E. coli HK97 (red), showing indentations in the red colonies where viral infection is spreading.DOMINIK REFARDTFor Escherichia coli, suicide can have fitness advantages in the face of deadly infection, even if the suicidal individual is surrounded by distantly related neighbors, according to new research published today (March 20) in The Proceedings of the Royal Society B: Biological Sciences. Researchers demonstrated that suicide designed to limit a virus’s spread through bacteria can still benefit the suicidal strain even if some the bacterial cells saved by the voluntary death are not related.

“The important thing here is that programmed death outcompetes non programmed death at a level other than the single cell, and that’s remarkable,” evolutionary biologist Pierre Durand of Witwatersrand University in South Africa, who did not participate in the research, said in an email to The Scientist. The study directly addresses how programmed cell death, or apoptosis, can benefit a bacterial population, showing how the phenomenon “is an adaptation . . . exposing the way in which programmed suicide enhances life,” noted Durand.

Suicide appears to be common to many organisms, from bacteria that undergo programmed cell death to insects that leave their hive to die when infected with a pathogen. It’s thought that this behavior evolved because it can benefit close relatives of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies